Understanding CARdiac Events in Breast Cancer
Understanding CARdiac Events in Breast Cancer - Pilot Cardio-Oncology Assessment and Surveillance Pathway for Breast Cancer Patients
National University of Ireland, Galway, Ireland
100 participants
Jan 14, 2023
OBSERVATIONAL
Conditions
Summary
In Ireland, over 3,000 patients are diagnosed with breast cancer annually, and 1 in 9 Irish women will be diagnosed with breast cancer in their lifetime. There is evidence that female breast cancer survivors are more likely to die of cardiovascular disease than their age-matched counterparts. This research is focused on evaluating pathways for identifying, managing, and overcoming side effects of cancer therapies that can negatively impact quality-of-life and overall outcomes for women during and after cancer treatment. The Cardio-oncology research team at GUH plan to capitalize on their expertise in both cancer care and cardiology to develop a care pathway for cancer patients who are at increased risk of developing heart disease.
Eligibility
Inclusion Criteria3
- Women aged ≥ 18 years
- Ability to read and understand English
- Breast Cancer Stage I- III planned to receive systemic chemotherapy
Exclusion Criteria3
- Patients not for systemic chemotherapy with curative intent
- Patients who are unable to co-operate with the study protocol
- Patients who are unable to give informed consent
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05921279